Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant

Cetuximab and panitumumab efficacy in metastatic colorectal cancer (mCRC) may be influenced by EGFR gene status and/or deregulation of its downstream signalling proteins detected in primary tumour. However, metastasis might have different molecular patterns with respect to primary tumour, possibly a...

Descripción completa

Detalles Bibliográficos
Autores principales: Molinari, F, Martin, V, Saletti, P, De Dosso, S, Spitale, A, Camponovo, A, Bordoni, A, Crippa, S, Mazzucchelli, L, Frattini, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669991/
https://www.ncbi.nlm.nih.gov/pubmed/19293803
http://dx.doi.org/10.1038/sj.bjc.6604848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669991/
https://www.ncbi.nlm.nih.gov/pubmed/19293803
http://dx.doi.org/10.1038/sj.bjc.6604848

Ejemplares similares